SCHEMBL7963516

SCHEMBL7963516

CCOC(=O)c1ccc2c(c1)c1cc(F)ccc1n2C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.49
PTGER4 P35408 1/20 0.48
ELANE P08246 2/20 0.47
MAPT P10636 6/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
CASP3 P42574 1/20 0.45
TRPV1 Q8NER1 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
NPY5R Q15761 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 4/20 0.44
HCRTR1 O43613 2/20 0.44
RAB9A P51151 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4728865 0.92 ATM (0.55) ATMPTGER4MAPTKMT2AMEN1
SCHEMBL4728742 0.86 PTGER4 (0.62) ATMPTGER4MAPTKMT2AMEN1
SCHEMBL4725234 0.85 ELANE (0.49) ATMPTGER4ELANEMAPTKMT2A
SCHEMBL7976974 0.81 NPY5R (0.50) PTGER4NPY5RALDH1A1KDM4EHPGD
SCHEMBL69334 0.76 CA12 (0.56) MAPTKMT2AMEN1CA12CA1
SCHEMBL7979591 0.76 KDM4E (0.72) MAPTKMT2AMEN1CASP3TRPV1
SCHEMBL21888553 0.75 RAB9A (0.53) PTGER4MAPTKMT2AALDH1A1KDM4E
SCHEMBL4727898 0.73 PTGER4 (0.53) PTGER4ELANEMAPTKMT2AMEN1
SCHEMBL2080278 0.73 ELANE (0.59) ELANERAB9ANPC1LMNA
SCHEMBL3830381 0.73 CA12 (0.56) MAPTKMT2AMEN1CASP3TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 WO disclosed